Analyzing Evaluation and Management of Diurnal Enuresis in Pediatrics
Preprint
- 3 September 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Diurnal enuresis, or daytime wetting, can significantly affect a child’s biopsychosocial well-being, however, there is a lack of diagnostic and management algorithms on the diagnosis. The purpose of this literature review is to analyze the efficacy of the evaluation and management of diurnal enuresis. A total of 44 articles published from January 1900 to December 2024 were chosen through literature searches in PubMed, Science Direct, Embase, and Google scholar were used. Search terms were “Diurnal Enuresis” or “Daytime Incontinence” as Mesh terms and subsequent terms included “pediatrics”, “urinary bladder, overactive”, and “therapeutics” to name a few. Inclusion criteria included studies involving pediatric study subjects starting at 5 years old with a specific diagnosis of diurnal enuresis, exclusion criteria were any studies before 1900 and studies involving night-time wetting diagnoses.A consensus among the literature and the American Academy of Family Physicians recommends that a stepwise diagnostic evaluation, including history taking followed by a focused and pertinent physical exam, for diurnal enuresis has proven to be the most effective. Regarding treatment, biofeedback was shown to improve symptoms in 74% of cases in one study by Wiener, while pharmacological treatment via Mirabegron (beta 3 agonist) showed 70% improvement in one study by Fryer, but older drugs such as oxybutynin (anticholinergics) are still preferred. However, most literature postulates that a multidisciplinary approach with TENS therapy, behavioral modification, biofeedback, and pharmacology can enhance effectiveness, improve reliability, and provide more successful results while minimizing the impact of diurnal enuresis on a child's overall well-being.Keywords
All Related Versions
This publication has 33 references indexed in Scilit:
- The combined effect of biofeedback training and osteopathic procedures for the treatment of functional daytime urinary incontinence: A prospective, randomized clinical trialJournal of Bodywork and Movement Therapies, 2024
- Efficacy of Biofeedback in Paediatric Urology Patients: A Single Centre ExperienceJournal of Pediatric Surgery, 2023
- Comparison and characteristics of children successfully treated for daytime urinary incontinenceJournal of Pediatric Urology, 2022
- Influence of constipation on enuresisAnales de Pediatría (English Edition), 2021
- Effectiveness and tolerability of mirabegron in children with overactive bladder: A retrospective pilot studyJournal of Pediatric Surgery, 2020
- Imipramine for refractory daytime incontinence in the pediatric populationJournal of Pediatric Urology, 2018
- Mirabegron in overactive bladder: A review of efficacy, safety, and tolerabilityNeurourology and Urodynamics, 2013
- Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive BladderEuropean Urology, 2013
- Treatment with Propiverine in Children Suffering from Nonneurogenic Overactive Bladder and Urinary Incontinence: Results of a Randomized Placebo-Controlled Phase 3 Clinical TrialEuropean Urology, 2009
- Tolterodine: an overviewWorld Journal of Urology, 2001